| 000 | 01683 a2200445 4500 | ||
|---|---|---|---|
| 005 | 20250517035856.0 | ||
| 264 | 0 | _c20160601 | |
| 008 | 201606s 0 0 eng d | ||
| 022 | _a2159-8290 | ||
| 024 | 7 |
_a10.1158/2159-8290.CD-15-0298 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aBehbehani, Gregory K | |
| 245 | 0 | 0 |
_aMass Cytometric Functional Profiling of Acute Myeloid Leukemia Defines Cell-Cycle and Immunophenotypic Properties That Correlate with Known Responses to Therapy. _h[electronic resource] |
| 260 |
_bCancer discovery _cSep 2015 |
||
| 300 |
_a988-1003 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, Non-P.H.S. | ||
| 650 | 0 | 4 |
_aAntineoplastic Combined Chemotherapy Protocols _xtherapeutic use |
| 650 | 0 | 4 | _aBiomarkers |
| 650 | 0 | 4 |
_aBone Marrow Cells _xmetabolism |
| 650 | 0 | 4 | _aBone Marrow Examination |
| 650 | 0 | 4 |
_aCell Cycle _xgenetics |
| 650 | 0 | 4 | _aCluster Analysis |
| 650 | 0 | 4 | _aFlow Cytometry |
| 650 | 0 | 4 | _aGenotype |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aImmunophenotyping |
| 650 | 0 | 4 | _aKaryotype |
| 650 | 0 | 4 |
_aLeukemia, Myeloid, Acute _xdiagnosis |
| 650 | 0 | 4 |
_aNeoplastic Stem Cells _xmetabolism |
| 650 | 0 | 4 | _aPhenotype |
| 650 | 0 | 4 | _aReproducibility of Results |
| 650 | 0 | 4 | _aTreatment Outcome |
| 700 | 1 | _aSamusik, Nikolay | |
| 700 | 1 | _aBjornson, Zach B | |
| 700 | 1 | _aFantl, Wendy J | |
| 700 | 1 | _aMedeiros, Bruno C | |
| 700 | 1 | _aNolan, Garry P | |
| 773 | 0 |
_tCancer discovery _gvol. 5 _gno. 9 _gp. 988-1003 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1158/2159-8290.CD-15-0298 _zAvailable from publisher's website |
| 999 |
_c24998734 _d24998734 |
||